| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/25/2000 | US6093800 Amino acid sequence of cell surface protein; diagnostic markers of cancer, including hormone refractory prostate cancer; anticarcinogenic agents |
| 07/25/2000 | US6093797 Modifications of the tripeptide hormone melanocyte stimulating inhibitory factor; can cross blood-brain barrier; side effect reduction |
| 07/25/2000 | US6093796 Recombinant hK2 polypeptide |
| 07/25/2000 | US6093795 Amino acid sequence of protein involved in eukaryotic transcription; for recombinant production; for screening agonists and antagonists to treat related disease states |
| 07/25/2000 | US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells |
| 07/25/2000 | US6093695 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP |
| 07/25/2000 | US6093694 Antitumor active substances |
| 07/25/2000 | US6093693 B cell activation |
| 07/25/2000 | US6093573 Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
| 07/25/2000 | US6093570 Cotransfecting cells permissive for adenovirus-associated virus replication with a recombinant adeno-associated virus vector, a helper adeno-associated virus vector and a helper virus vector to produce infectious virions and collecting |
| 07/25/2000 | US6093569 Introducing into regenerable plant cells a recombinant dna of a promoter of specific nucleotide sequence linked to a heterologous dna of interest, and identifying or selecting transformed cells; for high constitutive expression |
| 07/25/2000 | US6093567 Gene therapy for cystic fibrosis |
| 07/25/2000 | US6093558 Applying to a substrate an adhesive comprising a nonproteinaceous polymer of monomeric units comprising an aromatic moiety having hydroxyl group(s); contacting a bioactive protein (such as cell) with substrate to immobilize |
| 07/25/2000 | US6093556 Gene recombinant with biodegradability for chlorinated ethylene and bio-treatment of chlorinated ethylene therewith |
| 07/25/2000 | US6093554 Inducible production of proteins, peptides or rnas; dna derived from rna virus dependent upon viral rna/rna polymerase(rp), the derived sequence codes for cis elements for replication, but not viral rna/rp or viral coat protein |
| 07/25/2000 | US6093553 Immortalized brain endothelial cells |
| 07/25/2000 | US6093550 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 07/25/2000 | US6093549 Identifying candidate therapeutic agents which interfere with huntingtin associated protein-1(hap1) and huntingtin binding by contacting these proteins and a compound, determining if the compound diminishes the two proteins from binding |
| 07/25/2000 | US6093547 Morphogen cell surface receptor and screening for morphogen analogs |
| 07/25/2000 | US6093545 Contacting the sample with nucleic acid probe or primer and detecting hybridization to the target nucleic acid; diagnosis of nervous system disorders including eating and sleep disorders, irritable bowel and glandular disorders |
| 07/25/2000 | US6093544 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 07/25/2000 | US6093542 Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine RNA |
| 07/25/2000 | US6093540 Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor |
| 07/25/2000 | US6093539 Encodes a water-soluble polypeptide of portion of human cd4 glycoprotein able to complex with human immunodeficiency virus envelope glycoprotein; viricides; vaccines |
| 07/25/2000 | US6093535 By analyzing genomic dna present in a sample of varicella virus and determining if dna satisfies eight characteristics |
| 07/25/2000 | US6093533 Screening for modulators of bone resorption by culturing tartarate resistant acid phosphatase positive prefusion osteoclasts, osteoblasts, vitamin d3 or derivative and compound on a bone slice and measuring resorption |
| 07/25/2000 | US6093406 Vaccine for induction of immunity to malaria |
| 07/25/2000 | US6093405 Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines |
| 07/25/2000 | US6093400 Modified HGP-30 peptides, conjugates, compositions and methods of use |
| 07/25/2000 | US6093399 Specific blood coagulation exemplified by in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecific antibody |
| 07/25/2000 | US6093396 Modified glutamic acid decarboxylase (GAD) |
| 07/25/2000 | US6093395 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production |
| 07/25/2000 | US6093393 Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts |
| 07/25/2000 | US6093383 Bisamine bisthiol radiolabel binding moieties |
| 07/25/2000 | US6092764 Interface seal for an aircraft |
| 07/25/2000 | CA2286314A1 Human tumor suppressor gene |
| 07/25/2000 | CA2260332A1 Efficient non-viral transduction and culture of erythroid cells |
| 07/25/2000 | CA2160131C New bacillus thuringiensis strains and their insecticidal proteins |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/25/2000 | CA2091450C Plant parasitic nematode control |
| 07/25/2000 | CA2049325C Peptide, immunogenic composition and vaccine or medicinal preparation; a method immunising a mammal against lhrh, and a method of improving the meat quality of pigs |
| 07/25/2000 | CA2040595C Gene coded for a polypeptide which enhances virus infection of host insects |
| 07/25/2000 | CA2015377C Autoantibodies which enhance the rate of a chemical reaction |
| 07/25/2000 | CA2015077C A yeast cell of the genus schwanniomyces |
| 07/25/2000 | CA2010256C Protein anti-cancer agent |
| 07/25/2000 | CA1341060C Use of amylin agonists in the treatment of diabetes mellitus |
| 07/20/2000 | WO2000042437A1 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 07/20/2000 | WO2000042221A2 Method for the affinity isolation of newly synthesized rna |
| 07/20/2000 | WO2000042220A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/20/2000 | WO2000042219A1 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 07/20/2000 | WO2000042205A2 Herbicide target gene and methods |
| 07/20/2000 | WO2000042204A2 Trans-acting factors in yeast |
| 07/20/2000 | WO2000042197A1 Recombinant enzyme with excellent d-amino acid oxidase activity and production thereof |
| 07/20/2000 | WO2000042195A2 Schizochytrium pks genes |
| 07/20/2000 | WO2000042194A2 Mutant hepatitis b surface antigen and testing |
| 07/20/2000 | WO2000042193A1 Neisseria meningitidis antigen |
| 07/20/2000 | WO2000042192A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | WO2000042191A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/20/2000 | WO2000042189A1 Interleukin-20 |
| 07/20/2000 | WO2000042188A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042187A1 Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042186A1 NOVEL INTERFERON-$g(a) |
| 07/20/2000 | WO2000042184A1 Zlrr3: a human leucine-rich repeat protein |
| 07/20/2000 | WO2000042183A2 Tumor marker zsig62 |
| 07/20/2000 | WO2000042182A1 Mammalian cortexin-like proteins and polynucleotides encoding the same |
| 07/20/2000 | WO2000042181A1 Minor histocompatibility antigens and their use in diagnosis and treatment of tumors |
| 07/20/2000 | WO2000042180A1 Novel protein |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042176A1 Selection of monoclonal antibodies |
| 07/20/2000 | WO2000042175A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042171A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042166A2 Methods and compositions for monitoring cellular processing of epitope-tagged beta-amyloid precursor protein |
| 07/20/2000 | WO2000042165A2 Bone marrow-specific protein |
| 07/20/2000 | WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042070A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | WO2000042069A1 Bone stimulating factor |
| 07/20/2000 | WO2000042068A2 Hiv related peptides |
| 07/20/2000 | WO2000042066A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 07/20/2000 | WO2000042064A1 Peptides for inhibiting hpv e6 proteins |
| 07/20/2000 | WO2000042063A2 Peptides for inhibiting hbv core proteins |
| 07/20/2000 | WO2000041719A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041561A1 Bacterial cell component-unresponsive model mouse |
| 07/20/2000 | WO2000041548A2 Methods for glucagon suppression |
| 07/20/2000 | WO2000041546A2 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | WO2000041516A2 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | WO2000041509A2 Polypeptides having acid phosphatase activity and nucleic acids encoding same |
| 07/20/2000 | WO2000041508A2 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines |
| 07/20/2000 | WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | WO2000023591A3 Secreted protein zsig49 |
| 07/20/2000 | WO2000022132A3 Nucleic acids that control reproductive development in plants |
| 07/20/2000 | WO2000020590A3 G-protein coupled receptor proteins |
| 07/20/2000 | WO2000020589A3 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 07/20/2000 | WO2000020586A3 Renal cancer associated antigens and uses therefor |
| 07/20/2000 | WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 07/20/2000 | WO2000020018A8 Kappa-a conopeptides and uses therefor |
| 07/20/2000 | WO2000017363A3 Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses |